ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Quantum Dots for Biomedical Biosensing, NIR-II Bioimaging, and Phototherapy: Materials Design, Signal Transduction, and Translational Barriers.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Quantum dots (QDs) have emerged as standout candidates among inorganic nanomaterials, distinguished by their tunable photoluminescence, exceptional photostability, and size-dependent quantum confinement effects that enable tailored emission from the visible to the near-infrared range. These remarkable optical properties, coupled with broad absorption spectra and high quantum yields, have positioned QDs at the forefront of diverse biomedical applications. This review provides a systematic overview of QDs fabrication strategies, with a focus on bottom-up approaches, such as colloidal synthesis, hydrothermal, and solvothermal methods, as well as emerging biomimetic synthesis inspired by natural biomineralization. Additionally, we offer an in-depth discussion of cutting-edge QDs applications across three key areas: high-sensitivity biosensing for biomarker detection and point-of-care diagnostics; bioimaging, including fluorescence, magnetic resonance, and photoacoustic imaging; and intelligent nanocarrier-based cancer therapeutics, encompassing targeted drug delivery and imaging-guided precision surgery. Furthermore, this review examines the key challenges and optimization strategies for QDs in biomedical applications, with a particular focus on the critical bottlenecks impeding their clinical translation. By analyzing these barriers and outlining future directions, it aims to provide both theoretical and practical guidance for translating QDs from laboratory-scale innovations into routine clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.